Abo Dahab, L., Boghdady, A., Zaki, N., Abass, N. (2018). Study of Pulmonary Hypertension in Hemodialysis patients in Sohag University Hospital. test, 22(1), 423-429. doi: 10.21608/smj.2018.42519
Lotfy Hamed Abo Dahab; Ahmed Mohamed Boghdady; Nayel Abd ELhameed Zaki; Noher Mohammad Abass. "Study of Pulmonary Hypertension in Hemodialysis patients in Sohag University Hospital". test, 22, 1, 2018, 423-429. doi: 10.21608/smj.2018.42519
Abo Dahab, L., Boghdady, A., Zaki, N., Abass, N. (2018). 'Study of Pulmonary Hypertension in Hemodialysis patients in Sohag University Hospital', test, 22(1), pp. 423-429. doi: 10.21608/smj.2018.42519
Abo Dahab, L., Boghdady, A., Zaki, N., Abass, N. Study of Pulmonary Hypertension in Hemodialysis patients in Sohag University Hospital. test, 2018; 22(1): 423-429. doi: 10.21608/smj.2018.42519

Study of Pulmonary Hypertension in Hemodialysis patients in Sohag University Hospital

Sohag Medical Journal
Article 58, Volume 22, Issue 1, January 2018, Pages 423-429    PDF (73.63 K)
Document Type: Original Article
DOI: 10.21608/smj.2018.42519
Authors
Lotfy Hamed Abo Dahab1; Ahmed Mohamed Boghdady1; Nayel Abd ELhameed Zaki2; Noher Mohammad Abass3
1Department of Internal Medicine, Faculty of Medicine, Sohag University.
2Department of Internal Medicine, Faculty of Medicine, Sohag University.
3Department of Internal Medicine, Sohag Faculty of Medicine, Sohag University.
Supplementary Files
References
  1. Hill N.R, Fatoba S.T, Oke J.L, Hirst J.A, O’Callaghan C.A, Lasserson D.S: Global Prevalence of Chronic Kidney Disease, Systematic Review and Meta Analysis. PLoS ONE  2016; 11(7).
  2. Navaneethan S.D, Roy J, Tao K, Brecklin C.S, Chen J, Deo R, Flack J.M, Ojo A.O, Plappert T.J, Raj D.S, Saydain G, Sondheimer J.H, Sood R, Steigerwalt S.P, Townsend R.R, Dweik R.A, Rahman M: Chronic Renal Insufficiency Cohort Investigators: Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol 2016; 27: 877- 886
  3. Selvaraj S, Shah S.J, Ommerborn MJ: Pulmonary hypertension is associated with a higher risk of heart failure hospitalization and mortality in patients with chronic kidney disease: The Jackson Heart Study. Circ Heart Fail 2017; 6-10.
  4. Stallworthy E.J, Pilmore H.L, Webster M.W: Do echocardiographic parameters predict mortality in patients with end-stage renal disease? Transplantation. 2013; 95 (10): 1225–1232.
  5. Kawar B, Ellam T, Jackson C, Kiely D.G: Pulmonary hypertension in renal disease: Epidemiology, potential mechanisms and implications. Am J Nephrol 2013; 37: 281–290.
  6. Humbert M, Gerry Coghlan J, Khanna D: Early detection and management of pulmonary arterial hypertension. Eur Respir Rev  2012; 21: 306–312.
  7. Lawrence G, Rudski, Wyman W.L, Jonathan Afilalo, Lanqi Hua, Mark D. Handschumacher, Krishnaswamy Chandrasekaran, Scott D, Solomon, Eric K. Louie, and Nelson B. Schiller: Guidelines for the Echocardiographic Assessment of the right heart in adults American Society of EchocardiographyEndorsed by the European Association of Echocardiography. J Am Soc Echocardiogr 2010; 23:685-713.
  8. Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, Abassi Z, Reisner S.A: Pulmonary hypertension in patients with end-stage renal disease, Chest 2003; 123 (5): 1577–1582.
  9. Mahdavi-Mazdeh.M, Alijavad-Mousavi.S, Yahyazadeh.H, Azadi.M, Yoosef nejad.H, Ataiipoor.Y: Pulmonary hypertension in hemodialysis patients. Saudi J. Kidney Dis. Transpl  2008;19: 189–193.
  10. Abdelwhab S, Elshinnawy S: Pulmonary hypertension in chronic renal failure patients. Am. J. Nephrol 2008;28: 990–997.
  11. Sise M.E, Courtwright A.M, Channick R.N:  Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int 2013; 84: 682–692.
  12. Stauffer M.E, Fan T: Prevalence of anemia in chronic kidney disease in the United States. PLoS One.2014; 9: e84943.
  13. Tsai Y.C, Tsai J.C, Chen S.C, Chiu Y.W, Hwang S.J, Hung C.C, Chen T.H, Kuo M.C, Chen H.C: Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study. Am J Kidney Dis 2014; 63: 68–75.
  14. Magdy M.Emara, Mohamad A. Habeb, Alsayed Ahmed Alnahal, Tarek A. Elshazly, Faisal O. Alatawi, Amer S. Masoud:  Prevalence of pulmonary hypertension in patients with chronic kidney disease on and without dialysis. Egyptian Journal of Chest Diseases and Tuberculosis 2013; 62: 761–768
  15. Tarrass F, Benjelloun M, Medkouri G, Hachim K, Benghanem M.G: Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis. Hemodial Int2006; 10: 356-359.
  16. Kumbar L, Fein P.A, Rafiq M.A, Borawski C, Chattopadhyay J: Pulmonary hypertension in peritoneal dialysis patients. Adv Perit Dial 2007:23: 127-131.
  17. Jawad Kadhem Manuti: Pulmonary Hypertension in Patients with Chronic Renal Failure. IRAQI J MED SCI 7(2009): 104-108.
  18. Abdallah E.A, Waked E, Metwaly A, Khalek A.A: Role of arterio-venous shunt in the pathogenesis of pulmonary hypertension in patients with end stage renal disease. Kidney 2010; 19: 239.
  19. min M, Fawzy A, Hamid M.A, Elhendy A: Pulmonary hypertension in patients with chronic renal failure, role of parathyroid hormone and pulmonary artery calcifications. Chest 2003; 124: 2093-2097.
  20. Buemi M, Senatore M, Gallo G.C, Crasc E, Campo S, Sturiale A, Coppolino G, Bolignano D, Frisina N : Pulmonary hypertension and erythropoietin. Kidney Blood Press Res 2007; 30(4):248–252.
  21. Mousavi S.S, Tamadon M.R, Nasri H, Ardalan M.R: Impact of parathyroid hormone on pulmonary artery pressure in hemodialysis patients. J Parathyr Dis.  2014;  2: 71-2.
  22. Demir M, Uyan U, Keçeoçlu S, Demir C: The relationship between vitamin D deficiency and pulmonary hypertension. Prague Med Rep 2013; 114:154-61.
  23. Park M, Hsu C.Y, Li Y, Mishra R.K, Keane M, Rosas S.E,  Dries D, Xie D, Chen J, He J, Anderson A, Go A.S, Shlipak  M.G: Associations between kidney function and sub-clinical cardiac abnormalities in CKD. J Am Soc Nephrol 2012; 23:1725–1734.
  24. Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Cannella G: The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death  in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004; 19: 1829–1834.
Statistics
Article View: 180
PDF Download: 266